UNSPSC 51191707: Trometamol or tromethamine hydrochloride

This classification denotes an organic carcinogen with the molecular formula C4H11NO3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 383V75M34E. European Medicines Agency schedules tromethamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32380. Most nations, for tariff and trade purposes, schedule tromethamine hydrochloride under HS 29221990. As of Q4 2014, TROMETHAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C(C(CO)(CO)N)O.CL.

UNSPSC 51191707 Trometamol or tromethamine hydrochloride is a Commodity code that captures chemical supply for municipal water treatment and healthcare operations. Recent state and local solicitations under this code show municipalities and cooperative purchasing alliances procuring both specialized industrial chemicals for water pollution control and generic pharmaceuticals through multi-source distribution networks. The City of Meriden's IFB for sodium bisulfite (B027-15) exemplifies the water treatment use case, where municipalities source treatment chemicals for water pollution control facilities on a unit-cost basis with firm pricing and performance bonding requirements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals (S1070000015802), by contrast, illustrates the healthcare supply pathway, where cooperative purchasing vehicles aggregate demand across state and local government facilities and require vendors to supply through authorized wholesalers with cGMP certification and DSCSA compliance. Both opportunities reflect the code's scope: municipalities and state-administered cooperative purchasing entities are the primary issuing bodies, with insurance and bonding requirements calibrated to the scale and risk profile of each market segment.

The code shows activity in Connecticut (Meriden) and Minnesota (MMCAP membership spanning Minnesota and Oregon), with MMCAP representing a multi-state cooperative purchasing vehicle administered by the Minnesota Department of Administration's Office of State Procurement. The City of Meriden's sodium bisulfite bid closed July 29, 2026, with general liability and workers' compensation insurance requirements typical of municipal chemical supply contracts. MMCAP's RFP for generic pharmaceuticals and OTC products, posted January 20, 2026 with responses due March 26, 2026, evaluates vendors on fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), fee acceptance (5 percent), and price competitiveness (75 percent), with contract awards effective July 1, 2026. The RFP does not disclose specific award values or budget ranges, but vendors should anticipate a 3 percent administrative fee and performance penalties of $200 to $1,500 per violation.